Protein and its use in diagnosing Alzheimer's disease
AssigneeNymox Corporation
InventorsPaul Averback, Jack Gemmell
Life of this patent
Estimating the term…
Abstract
Embodiments are directed to a peptide and protein containing that peptide, nucleic acids, antibodies, as well assays detecting the peptide or protein, and methods of identifying patients with or at risk of developing Alzheimer's Disease and other neurodegenerative diseases.
Claims26
A peptide having the amino acid sequence of SEQ ID NO:14.
A peptide encoded by the nucleic acid sequence of SEQ ID NO:15 or by a sequence that hybridizes to the nucleic acid sequence of SEQ ID NO:15 under stringent conditions.
A composition comprising a peptide having the amino acid sequence of SEQ ID NO:14
A polynucleotide having the nucleic acid sequence of SEQ ID NO:15.
A polynucleotide that encodes an amino acid sequence of SEQ ID NO:14
An antibody that specifically recognizes (a) a peptide having the amino acid sequence of SEQ ID NO:14;
- (b) a peptide encoded by the nucleic acid sequence of SEQ ID NO:15;
- or (c) a peptide encoded by a nucleic acid sequence that hybridizes under stringent conditions to the nucleic acid sequence of SEQ ID NO:15.
Dependencies are inferred from the claim text.